Company Filing History:
2 out of 2,081 
2 out of 21 
Years Active: 2012
Title: John Harrison: Innovator in Alzheimer's Disease Treatment
Introduction
John Harrison is a distinguished inventor based in Cambridge, GB, known for his contributions to the pharmaceutical field. With two patents to his name, Harrison has made significant strides in developing potential treatments for diseases associated with γ-secretase activity, particularly Alzheimer's disease.
Latest Patents
Harrison's latest patents include:
1. **Piperidinyl and Piperazinyl Modulators of γ-Secretase** - This invention pertains to compounds of Formula I that have specific definitions for various components as detailed in the specification. These compounds are noted for their potential utility in treating conditions linked to γ-secretase activity, especially Alzheimer's disease.
2. **Amine Linked Modulators of γ-Secretase** - Similar in focus to his previous patent, this invention also relates to compounds of Formula I, defined precisely in the specification. These compounds aim to address diseases associated with γ-secretase, including Alzheimer’s, providing hope for new therapeutic avenues.
Career Highlights
Throughout his career, John Harrison has worked with prominent organizations such as Janssen Pharmaceutica NV and Cellzome Limited. His experience in these reputable companies has contributed significantly to his expertise in drug development and innovation.
Collaborations
Harrison has collaborated with notable coworkers, including Chih Yung Ho and Yan Zhang. Their combined efforts in research and development have likely fostered significant advancements in the understanding and treatment of complex diseases.
Conclusion
John Harrison stands out as a key figure in the field of pharmaceutical innovation. His patents demonstrate a commitment to addressing challenging health issues like Alzheimer's disease, and his collaborations reflect a synergy that is essential for continued progress in medical science. Harrison's work is a testament to the impact that inventors can have on healthcare advancements.